Japan approves AI software that uses MRI scans to identify depression, aiming to make diagnosis more objective.
Key Details
- 1AI algorithm detects signs of depression by analyzing MRI brain scans.
- 2Developed by the Advanced Telecommunications Research Institute International in Japan.
- 3Software provides visual evidence of brain activity alterations linked to depression.
- 4Regulatory approval granted in Japan; type not specified (likely a medical device approval).
- 5Conventional depression diagnoses typically rely on subjective patient reports and interviews.
Why It Matters
Objective tools for diagnosing depression could improve accuracy, standardization, and treatment selection in mental health care. The approval highlights expanding clinical roles for imaging AI, especially in neuropsychiatric applications.
Source
Health Imaging
Related News
•AuntMinnie
Paul Chang Discusses Foundation Models and Agentic AI at RSNA 2025
Dr. Paul Chang shares his insights on the role of foundation models and agentic AI in radiology at RSNA 2025.
•AuntMinnie
Toronto Study: LLMs Must Cite Sources for Radiology Decision Support
University of Toronto researchers found that large language models (LLMs) such as DeepSeek V3 and GPT-4o offer promising support for radiology decision-making in pancreatic cancer when their recommendations cite guideline sources.
•Radiology Business
AI Tool Outperforms Radiologists in Pancreatic Cancer Detection
AI demonstrated superior accuracy over radiologists in detecting pancreatic cancer, according to new comparative data.